The Prize Fight for Progress: Pfizer Snags Metacrine in a High-Stakes Metabolic Drug Scramble
The $11.6 Billion Bet: Pfizer Jumps Headfirst into the Weight Loss Race
The $10 Billion Gamble: Pfizer's Bold Leap into the Weight-Loss Frontier